SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-20-000432
Filing Date
2020-05-01
Accepted
2020-05-01 07:06:50
Documents
4
Period of Report
2020-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e1889_8k.htm 8-K 22397
2 EXHIBIT 1.1 e1889_ex1-1.htm EX-1.1 254231
3 EXHIBIT 5.1 e1889_ex5-1.htm EX-5.1 9357
4 EXHIBIT 5.2 e1889_ex5-2.htm EX-5.2 10122
  Complete submission text file 0001731122-20-000432.txt   297400
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 20838324
SIC: 8731 Services-Commercial Physical & Biological Research